Thermo Fisher Scientific Inc. (NYSE:TMO) declared a quarterly dividend on Friday, November 8th, RTT News reports. Stockholders of record on Tuesday, December 17th will be paid a dividend of 0.19 per share by the medical research company on Wednesday, January 15th. This represents a $0.76 annualized dividend and a dividend yield of 0.26%.
Shares of Thermo Fisher Scientific stock traded down $0.41 on Friday, hitting $293.13. 113,194 shares of the company were exchanged, compared to its average volume of 1,323,858. The stock has a market capitalization of $117.34 billion, a price-to-earnings ratio of 26.36, a price-to-earnings-growth ratio of 1.90 and a beta of 1.14. The company has a 50-day moving average price of $290.18 and a 200 day moving average price of $283.40. Thermo Fisher Scientific has a 1-year low of $208.34 and a 1-year high of $306.00. The company has a quick ratio of 1.23, a current ratio of 1.80 and a debt-to-equity ratio of 0.56.
Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings data on Wednesday, October 23rd. The medical research company reported $2.94 EPS for the quarter, beating analysts’ consensus estimates of $2.88 by $0.06. Thermo Fisher Scientific had a return on equity of 17.16% and a net margin of 14.24%. The firm had revenue of $6.27 billion for the quarter, compared to analysts’ expectations of $6.19 billion. During the same period in the prior year, the firm posted $2.62 earnings per share. The firm’s quarterly revenue was up 5.9% on a year-over-year basis. Research analysts forecast that Thermo Fisher Scientific will post 12.33 EPS for the current year.
In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 2,271 shares of the business’s stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $298.00, for a total value of $676,758.00. Following the sale, the chief executive officer now owns 283,502 shares of the company’s stock, valued at $84,483,596. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Jim P. Manzi sold 1,833 shares of the business’s stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $272.93, for a total value of $500,280.69. Following the completion of the sale, the director now directly owns 28,592 shares in the company, valued at approximately $7,803,614.56. The disclosure for this sale can be found here. Insiders sold 51,833 shares of company stock worth $15,299,095 over the last quarter. 0.45% of the stock is currently owned by insiders.
A number of research analysts recently commented on the company. Barclays set a $330.00 price objective on Thermo Fisher Scientific and gave the company a “buy” rating in a report on Monday, July 15th. Credit Suisse Group reiterated a “buy” rating and issued a $310.00 price objective on shares of Thermo Fisher Scientific in a report on Wednesday, July 31st. Robert W. Baird upped their price objective on Thermo Fisher Scientific from $305.00 to $319.00 and gave the company an “outperform” rating in a report on Thursday, October 24th. ValuEngine cut Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Finally, Needham & Company LLC upped their price objective on Thermo Fisher Scientific from $315.00 to $321.00 and gave the company a “buy” rating in a report on Thursday, July 25th. One research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $314.45.
Thermo Fisher Scientific Company Profile
Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.
Read More: Straddles
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.